FitLife Brands Inc

FitLife Brands Inc(FTLF)股票分析

$8.000

-0.176 (-2.20%)收盘时

Loading chart…
最高
8.120
开盘
8.120
成交量加权均价
8.04
成交量
6.95K
市值
151.74M
最低
8.000
成交额
55.85K
企业价值/息税折旧摊销前利润(TTM)
7.55

FitLife Brands, Inc. is a developer and marketer proprietary nutritional supplements and wellness products for health-conscious consumers. It markets approximately 250 different products primarily online, through domestic and international GNC franchise locations as well as through various retail locations. It offers NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition (together, NDS Products); iSatori, BioGenetic Laboratories, and Energize (together, the iSatori Products); Dr. Tobias, All Natural Advice, and Maritime Naturals (together, the MRC Products) and MusclePharm. Its NDS brand includes premium weight loss, sports nutrition, and general health products. Its PMD brand includes premium sports nutrition products. Its Nutrology brand included sports nutrition and general wellness products with an emphasis on natural, vegan, and organic ingredients. Its SirenLabs brand includes weight loss and sports nutrition products.

AI 分析 of FitLife Brands Inc (FTLF)

持有

Currently, FitLife Brands Inc (FTLF) is not a strong buy due to its low RSI of 37.37, indicating potential oversold conditions, and a significant year-to-date decline of 49.05%. Although there was a recent revenue growth of 65% year-over-year in Q2 2026, the company's gross margin has declined to 36.01%. The upcoming earnings report on November 16, 2026, could provide more clarity, but the current price of $8.03 and the forward P/E of 6.11 suggest caution as the stock is still underperforming.

估值指标

FitLife Brands Inc(FTLF)当前预期市盈率为 6.26,5 年平均预期市盈率为 7.67。

预期市盈率

合理
5 年均值 P/E
7.67
当前P/E
6.26
高估
14.10
低估
1.24

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
5.63
当前EV/EBITDA
7.55
高估
10.22
低估
1.04

预期市销率

合理
5 年均值 P/S
0.93
当前P/S
0.68
高估
1.78
低估
0.09

事件时间线

2026-04-01 (ET)

16:30:00

Major Averages Close Broadly Higher as Market Sentiment Improves

12:20:00

Major Averages Broadly Higher as Market Sentiment Improves

07:10:00

Legacy FitLife Reports Q4 Revenue of $25.9M

2025-11-13 (ET)

07:36:28

FitLife Brands Announces Q3 EPS of 9 Cents Compared to 21 Cents Last Year

2025-08-14 (ET)

07:03:17

FitLife Brands reports Q2 EPS 18c vs. 27c last year

资讯

FTLF 常见问题 —— 由 Alphio AI 解答

FitLife Brands, Inc. is a developer and marketer proprietary nutritional supplements and wellness products for health-conscious consumers. It markets approximately 250 different products primarily online, through domestic and international GNC franchise locations as well as through various retail locations. It offers NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition (together, NDS Products); iSatori, BioGenetic Laboratories, and Energize (together, the iSatori Products); Dr. Tobias, All Natural Advice, and Maritime Naturals (together, the MRC Products) and MusclePharm. Its NDS brand includes premium weight loss, sports nutrition, and general health products. Its PMD brand includes premium sports nutrition products. Its Nutrology brand included sports nutrition and general wellness products with an emphasis on natural, vegan, and organic ingredients. Its SirenLabs brand includes weight loss and sports nutrition products. It operates in the Consumer Non-Cyclicals sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Currently, FitLife Brands Inc (FTLF) is not a strong buy due to its low RSI of 37.37, indicating potential oversold conditions, and a significant year-to-date decline of 49.05%. Although there was a recent revenue growth of 65% year-over-year in Q2 2026, the company's gross margin has declined to 36.01%. The upcoming earnings report on November 16, 2026, could provide more clarity, but the current price of $8.03 and the forward P/E of 6.11 suggest caution as the stock is still underperforming.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易